These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
3. 1,000 renal transplants at the Massachusetts General Hospital: improved allograft survival for high-risk patients without regard to HLA matching. Delmonico FL; Fuller TC; Cosimi AB Clin Transpl; 1990; ():247-53. PubMed ID: 2103150 [TBL] [Abstract][Full Text] [Related]
5. The impact of repeated HLA mismatches on the outcome of renal allograft retransplantation. Povlsen JV; Madsen M; Birkeland SA; Løkkegaard H; Pedersen EB; Svejgaard A; Olgaard K; Fjeldborg O Transplant Proc; 1992 Feb; 24(1):307-8. PubMed ID: 1539288 [No Abstract] [Full Text] [Related]
6. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team. Martin S; Connolly J; Jos V Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295 [No Abstract] [Full Text] [Related]
12. Tissue typing and the survival of renal grafts. Mebel M Acta Med Pol; 1978; 19(1-2):67-9. PubMed ID: 367077 [No Abstract] [Full Text] [Related]
13. Effect of reexposure to mismatched major histocompatibility complex antigens on renal retransplant allograft survival. Farney AC; Noreen HJ; Sutherland DE; Reinsmoen N; Segall M; Gillingham K; Schmidt WJ; Matas AJ Transplant Proc; 1993 Feb; 25(1 Pt 1):213-4. PubMed ID: 8438275 [No Abstract] [Full Text] [Related]
14. Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report. Moen T; Berger L; Goyer K; Dahl O; Thorsby E Scand J Urol Nephrol Suppl; 1981; 64():30-7. PubMed ID: 6815792 [No Abstract] [Full Text] [Related]
15. Cadaveric kidney exchange on the basis of HLA-matching is already cost-effective in the first year after grafting. Christiaans MH; van den Berg-Loonen PM; Nieman FH; Cohen B; Kootstra G; van Hooff JP Transplant Proc; 1993 Feb; 25(1 Pt 2):1685-6. PubMed ID: 8442236 [No Abstract] [Full Text] [Related]
16. The correlation of tissue typing, mixed lymphocyte culture, and related donor renal allograft survival. Cerilli J; Newhouse YG; Williams MA Transplant Proc; 1978 Dec; 10(4):953-4. PubMed ID: 153622 [No Abstract] [Full Text] [Related]
17. HLA matching effect: better survival rates and graft quality. Cho YW; Cecka JM; Terasaki PI Clin Transpl; 1994; ():435-49. PubMed ID: 7547574 [TBL] [Abstract][Full Text] [Related]
18. Impact of ethnicity, donor status and HLA matching on renal allograft survival: a single center study. Chelluri LK; Vasantha A; Ratnakar KS Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):995-7. PubMed ID: 19861859 [TBL] [Abstract][Full Text] [Related]
19. The influence of HLA matching in cardiac allograft recipients in a single center. Raffoux C; Mayor V; Cabrol C; Busson M; Hors J; Colombani J Transplant Proc; 1987 Oct; 19(5):3559-60. PubMed ID: 3313858 [No Abstract] [Full Text] [Related]
20. Renal transplantation in highly sensitized patients: five years of the SOS Scheme. Klouda PT; Corbin SA; Ray TC; Rogers CA; Bradley BA Clin Transpl; 1990; ():69-73. PubMed ID: 2103180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]